Warung Bebas

Rabu, 30 Oktober 2013

Mesothelioma Law Firm


Many millions of homes across the United States contain the construction material, asbestos. This is because, the majority of the 20th century, asbestos was highly regarded for its fire-proofing qualities. Therefore the material can be found in the average American home: the walls, the roofs, chimneys, floor and ceiling tiles, insulation material, ducting and heating systems.

When left undisturbed asbestos is perfectly safe and there is no need to be alarmed. However, if there is any damage or disturbance to asbestos, it can cause asbestos fibers to become airborne. These fibers may be come lodged within an individual’s lungs. Once lodged these hazardous fibers can cause a number of life-threatening illnesses. Such fibers are identified with difficulty as they do not show up in conventional x-rays.

The dangers of asbestos have been known for a considerable period of time. However many manufacturers of construction materials and employers continued to expose homeowners and employees to the material.

The illnesses that are most likely to affect those exposed to asbestos are asbestosis, mesothelioma, lung cancer and chronic obstructive pulmonary disease. These illnesses and, in particular, mesothelioma is life-threatening as they can take many years to diagnose. Diagnosis is only real possible once the symptoms become apparent. It is a feature of asbestos exposure that symptoms can take many years to manifest themselves. By the time symptoms do become apparent, it is often too late for the doctors to successfully treat the sufferer. That is not to say sufferers cannot be treated but treatment is difficult.

If you or anyone you know have been exposed to asbestos, or have worked in the construction industry, you may be able to file a lawsuit against the person or party responsible for your exposure. A mesothelioma law firm will be able to help you in this case. Filing a lawsuit can be a technical exercise and therefore you should only consider appointing a firm of lawyers who have experience in bringing such cases. A court may award you compensation for the exposure, there could be an award of medical bills, as well as further treatment costs.


DISCLAIMER: Information posted or made available on or through this Website, including without limitation any articles, comments, opinions, recommendations, answers, links, analysis, references, referrals or legally related content or information (collectively "Legal Information") is not intended as legal advice or to create an attorney-client relationship between you and any attorney. Such Legal Information is intended for general informational purposes only and should be used only as a starting point for addressing your legal issues. It is not a substitute for an in-person or telephone consultation with an attorney licensed to practice in your jurisdiction about your specific legal issue, and you should not rely upon such Legal Information. Nothing that is made available on this Website, including without limitation any question or answers posted on this Website, is subject to attorney-client privilege.

We have no control over and we do not warrant or guarantee the accuracy, adequacy, applicability, completeness or quality of any such Legal Information or the qualifications of anyone providing such Legal Information. NEITHER MINDSPARK INTERACTIVE NETWORK, INC. NOR ITS AGENTS AND SERVICE PROVIDES SHALL HAVE ANY RESPONSIBILITY OR LIABILITY OF ANY KIND FOR ANY LEGAL INFORMATION YOU ENCOUNTER ON OR THROUGH THIS WEBSITE, AND ANY USE OR RELIANCE ON LEGAL INFORMATION IS SOLELY AT YOUR OWN RISK

The Legal Background

People who find out that they are suffering from mesothelioma (often as a result of working with asbestos) usually have an excellent chance of recovering substantial money damages -- either from the company that manufactured or installed the asbestos, or from an asbestos victims' trust fund. But these cases can get complex, especially from a medical standpoint, since mesothelioma often shows up 10 to 40 years after exposure to asbestos. Having an experienced attorney on your side -- especially one with a record of success in mesothelioma cases -- can make all the difference. (To learn more about mesothelioma cases, read Nolo's article Asbestos and Mesothelioma Lawsuits: What to Expect.)
Finding the right mesothelioma lawyer can be key to your case, but it can also take time and effort. If you are not feeling well, make sure you get help from a consumer savvy relative or friend. As discussed below, you'll get the best results if you do careful research as to a lawyer's qualifications and track record and then interview several. You also may need to bargain as to the amount of the contingency fee and other costs.

Ways to Find the Right Mesothelioma Lawyer

Ask former colleagues. If you have been diagnosed with mesothelioma, chances are good that people who you worked with at the time of your exposure also suffer from it and may have already hired a lawyer and filed a lawsuit. If they have achieved a good result through a lawyer they like and respect, this is one good place to start.
Check Nolo's online Lawyer Directory. Some attorneys featured in Nolo's lawyer directory handle mesothelioma cases (full disclosure: lawyers pay a fee to list with Nolo). These attorneys have filled out a detailed profile containing valuable information about their schooling, professional background, legal specialties, and personal attitudes. While there are also a number of other legal directories, we believe Nolo's provides the most consumer friendly information. Go to the Mesothelioma - Asbestos section of Nolo's Lawyer Directory to find a mesothelioma attorney in your area.
Investigate lawyers online. Because mesothelioma cases can be so profitable, many law firms spend big dollars on Internet ads and websites. Just Google mesothelioma lawyer and you'll find a long list. Click on a few ads or websites and you'll see that everyone claims to be the best of the best. How do you cut through all this hype to focus on a short list of hopefully excellent mesothelioma lawyers? We recommend that you carefully read the legal information each lawyer provides. In our experience lawyers who provide well-written, in-depth information demonstrate a superior sensitivity to client needs. By the same token, we distrust lawyers who say little more than "I can get you millions pronto -- trust me."

How to Choose the Right Mesothelioma Lawyer

Check a lawyer's references. A good mesothelioma lawyer should be able to provide you with the name and contact information of a few satisfied clients. Of course, the lawyer will have to get the permission of the client, but this can usually be arranged. Although you'll only be given the names of very satisfied clients, it can still be very helpful to talk to someone who has worked with the lawyer you are considering in a mesothelioma case.
Interview the lawyers. Once you develop a short list of mesothelioma lawyers, contact their offices (again, get help if you are very ill). Request a case evaluation and, if possible, arrange a personal interview. Ask who exactly will manage your case (often a case manager, who is a non-lawyer in larger firms). Find out who you can call or email if you have questions, and how long it will take to get back to you. Anticipating these questions, many law firms will give you a written overview of what to expect. Especially if it's detailed and guarantees that all calls and emails will be returned in 24 hours, this is a good sign.
Negotiate fees with the lawyer. Mesothelioma lawyers charge a contingency fee for their legal representation, plus additional costs to prepare your case. One good approach is to contact several lawyers, making it clear that you'll take your time before signing a fee agreement. Your goal is to find a good quality lawyer who will represent you for 25% to 30% of your recovery, instead of 33% to 40%. But keep in mind that mesothelioma cases can be very complex. If you find an attorney who comes well-recommended and has a lot of experience (and a record of success) representing mesothelioma clients, a few percentage points on a contingency fee probably shouldn't dictate whether or not you hire that attorney.
Find out how are costs handled. A good attorney will deduct costs (things like filing fees and expert witnesses' compensation) off the top of any settlement or award, before the money is divided and the attorney takes their agreed-upon percentage. That way you and the attorney share payment of the costs. And a good attorney will give you receipts showing that all costs incurred were specific to your case -- meaning you're not being saddled with part of the bill for the firm's general operating expenses.

Mesothelioma (or, more precisely, malignant mesothelioma) is a rare form of cancer that develops from cells of the mesothelium, the protective lining that covers many of the internal organs of the body. Mesothelioma is most commonly caused by exposure to asbestos.[1] The most common anatomical site for mesothelioma is the pleura (the outer lining of the lungs and internal chest wall), but it can also arise in the peritoneum (the lining of the abdominal cavity), the pericardium (the sac that surrounds the heart),[2] or the tunica vaginalis (a sac that surrounds the testis).
Most people who develop mesothelioma have worked in jobs where they inhaled or ingested asbestos fibers, or were exposed to airborne asbestos dust and fibers in other ways. Washing clothes of a family member who worked with asbestos also creates a risk for developing mesothelioma.[3] Unlike lung cancer, there seems to be no association between mesothelioma and tobacco smoking, but smoking greatly increases the risk of other asbestos-induced cancers.[4]
Signs and symptoms of mesothelioma include shortness of breath due to pleural effusion (fluid between the lung and the chest wall), chest wall pain, and constitutional signs such as unexplained weight loss. The diagnosis may be suspected based on chest X-ray and CT scan findings, but must be confirmed either by examining serous effusion cytology or with a biopsy (removing a sample of the suspicious tissue). A thoracoscopy (inserting a tube with a camera into the chest) can be used to acquire biopsy material, and allows the introduction of substances such as talc to obliterate the pleural space (a procedure called pleurodesis), preventing more fluid from accumulating and pressing on the lung. Despite treatment with chemotherapy, radiation therapy or sometimes surgery, mesothelioma carries a poor prognosis. Research about screening tests for the early detection of mesothelioma is ongoing.

Signs and symptoms

Symptoms or signs of mesothelioma may not appear until 20 to 50 years (or more) after exposure to asbestos. Shortness of breath, cough, and pain in the chest due to an accumulation of fluid in the pleural space (pleural effusion) are often symptoms of pleural mesothelioma.[5]
Symptoms of peritoneal mesothelioma include weight loss and cachexia, abdominal swelling and pain due to ascites (a buildup of fluid in the abdominal cavity). Other symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia, and fever. If the cancer has spread beyond the mesothelium to other parts of the body, symptoms may include pain, trouble swallowing, or swelling of the neck or face.
These symptoms may be caused by mesothelioma or by other, less serious conditions.
Mesothelioma that affects the pleura can cause these signs and symptoms:[5]
  • Chest wall pain
  • Pleural effusion, or fluid surrounding the lung
  • Shortness of breath
  • Fatigue or anemia
  • Wheezing, hoarseness, or cough
  • Blood in the sputum (fluid) coughed up (hemoptysis)
In severe cases, the person may have many tumor masses. The individual may develop a pneumothorax, or collapse of the lung. The disease may metastasize, or spread, to other parts of the body.
Tumors that affect the abdominal cavity often do not cause symptoms until they are at a late stage. Symptoms include:
  • Abdominal pain
  • Ascites, or an abnormal buildup of fluid in the abdomen
  • A mass in the abdomen
  • Problems with bowel function
  • Weight loss
In severe cases of the disease, the following signs and symptoms may be present:
  • Blood clots in the veins, which may cause thrombophlebitis
  • Disseminated intravascular coagulation, a disorder causing severe bleeding in many body organs
  • Jaundice, or yellowing of the eyes and skin
  • Low blood sugar level
  • Pleural effusion
  • Pulmonary emboli, or blood clots in the arteries of the lungs
  • Severe ascites
A mesothelioma does not usually spread to the bone, brain, or adrenal glands. Pleural tumors are usually found only on one side of the lungs.

Cause

Working with asbestos is the major risk factor for mesothelioma.[6] In the United States, asbestos is the major cause of malignant mesothelioma[7] and has been considered "indisputably"[8] associated with the development of mesothelioma. Indeed, the relationship between asbestos and mesothelioma is so strong that many consider mesothelioma a “signal” or “sentinel” tumor.[9][10][11][12] A history of asbestos exposure exists in most cases. However, mesothelioma has been reported in some individuals without any known exposure to asbestos. In rare cases, mesothelioma has also been associated with irradiation, intrapleural thorium dioxide (Thorotrast), and inhalation of other fibrous silicates, such as erionite. Some studies suggest that simian virus 40 (SV40) may act as a cofactor in the development of mesothelioma. This has been confirmed in animal studies,[13][14] but studies in humans are inconclusive.[13][15][16]
Asbestos was known in antiquity, but it was not mined and widely used commercially until the late 19th century. Its use greatly increased during World War II. Since the early 1940s, millions of American workers have been exposed to asbestos dust. Initially, the risks associated with asbestos exposure were not publicly known. However, an increased risk of developing mesothelioma was later found among shipyard workers, people who work in asbestos mines and mills, producers of asbestos products, workers in the heating and construction industries, and other tradespeople. Today, the official position of the U.S. Occupational Safety and Health Administration (OSHA) and the U.S. EPA is that protections and "permissible exposure limits" required by U.S. regulations, while adequate to prevent most asbestos-related non-malignant disease, they are not adequate to prevent or protect against asbestos-related cancers such as mesothelioma.[17] Likewise, the British Government's Health and Safety Executive (HSE) states formally that any threshold for mesothelioma must be at a very low level and it is widely agreed that if any such threshold does exist at all, then it cannot currently be quantified. For practical purposes, therefore, HSE assumes that no such "safe" threshold exists. Others have noted as well that there is no evidence of a threshold level below which there is no risk of mesothelioma.[18] There appears to be a linear, dose-response relationship, with increasing dose producing increasing disease.[19] Nevertheless, mesothelioma may be related to brief, low level or indirect exposures to asbestos.[8] The dose necessary for effect appears to be lower for asbestos-induced mesothelioma than for pulmonary asbestosis or lung cancer.[8] Again, there is no known safe level of exposure to asbestos as it relates to increased risk of mesothelioma.
The duration of exposure to asbestos causing mesothelioma can be short. For example, cases of mesothelioma have been documented with only 1–3 months of exposure.[20][21] People who work with asbestos wear personal protective equipment to lower their risk of exposure.
Latency, the time from first exposure to manifestation of disease, is prolonged in the case of mesothelioma. It is virtually never less than fifteen years and peaks at 30–40 years.[8] In a review of occupationally related mesothelioma cases, the median latency was 32 years.[22] Based upon the data from Peto et al., the risk of mesothelioma appears to increase to the third or fourth power from first exposure.[19]

Environmental exposures

Incidence of mesothelioma had been found to be higher in populations living near naturally occurring asbestos. For example, in central Cappadocia, Turkey, mesothelioma was causing 50% of all deaths in three small villages—Tuzköy, Karain and Sarıhıdır. Initially, this was attributed to erionite, a zeolite mineral with similar properties to asbestos. Recently, however, detailed epidemiological investigation showed that erionite causes mesothelioma mostly in families with a genetic predisposition.[23][24] The documented presence of asbestos fibers in water supplies and food products has fostered concerns about the possible impact of long-term and, as yet, unknown exposure of the general population to these fibers.

Occupational

Exposure to asbestos fibers has been recognized as an occupational health hazard since the early 20th century. Numerous epidemiological studies have associated occupational exposure to asbestos with the development of pleural plaques, diffuse pleural thickening, asbestosis, carcinoma of the lung and larynx, gastrointestinal tumors, and diffuse malignant mesothelioma of the pleura and peritoneum. Asbestos has been widely used in many industrial products, including cement, brake linings, gaskets, roof shingles, flooring products, textiles, and insulation.
Commercial asbestos mining at Wittenoom, Western Australia, occurred between 1945 and 1966. A cohort study of miners employed at the mine reported that while no deaths occurred within the first 10 years after crocidolite exposure, 85 deaths attributable to mesothelioma had occurred by 1985. By 1994, 539 reported deaths due to mesothelioma had been reported in Western Australia.

Paraoccupational secondary exposure

Family members and others living with asbestos workers have an increased risk of developing mesothelioma, and possibly other asbestos related diseases.[25][26] This risk may be the result of exposure to asbestos dust brought home on the clothing and hair of asbestos workers. To reduce the chance of exposing family members to asbestos fibres, asbestos workers are usually required to shower and change their clothing before leaving the workplace.

Asbestos in buildings

Many building materials used in both public and domestic premises prior to the banning of asbestos may contain asbestos. Those performing renovation works or DIY activities may expose themselves to asbestos dust. In the UK use of Chrysotile asbestos was banned at the end of 1999. Brown and blue asbestos was banned in the UK around 1985. Buildings built or renovated prior to these dates may contain asbestos materials.

Diagnosis


CXR demonstrating a mesothelioma

CT scan of a patient with mesothelioma, coronal section (the section follows the plane that divides the body in a front and a back half). The mesothelioma is indicated by yellow arrows, the central pleural effusion (fluid collection) is marked with a yellow star. Red numbers: (1) right lung, (2) spine, (3) left lung, (4) ribs, (5) descending part of the aorta, (6) spleen, (7) left kidney, (8) right kidney, (9) liver.

Micrograph of a pleural fluid cytopathology specimen showing mesothelioma.

Micrographs showing mesothelioma in a core biopsy.
Diagnosing mesothelioma is often difficult, because the symptoms are similar to those of a number of other conditions. Diagnosis begins with a review of the patient's medical history. A history of exposure to asbestos may increase clinical suspicion for mesothelioma. A physical examination is performed, followed by chest X-ray and often lung function tests. The X-ray may reveal pleural thickening commonly seen after asbestos exposure and increases suspicion of mesothelioma.[5] A CT (or CAT) scan or an MRI is usually performed. If a large amount of fluid is present, abnormal cells may be detected by cytopathology if this fluid is aspirated with a syringe. For pleural fluid, this is done by thoracentesis or tube thoracostomy (chest tube); for ascites, with paracentesis or ascitic drain; and for pericardial effusion with pericardiocentesis. While absence of malignant cells on cytology does not completely exclude mesothelioma, it makes it much more unlikely, especially if an alternative diagnosis can be made (e.g. tuberculosis, heart failure). Using conventional cytology diagnosis of malignant mesothelioma is difficult, but immunocytochemistry has greatly enhanced the accuracy of cytology.
Generally, a biopsy is needed to confirm a diagnosis of malignant mesothelioma. A doctor removes a sample of tissue for examination under a microscope by a pathologist. A biopsy may be done in different ways, depending on where the abnormal area is located. If the cancer is in the chest, the doctor may perform a thoracoscopy. In this procedure, the doctor makes a small cut through the chest wall and puts a thin, lighted tube called a thoracoscope into the chest between two ribs. Thoracoscopy allows the doctor to look inside the chest and obtain tissue samples. Alternatively, the chest surgeon might directly open the chest (thoracotomy). If the cancer is in the abdomen, the doctor may perform a laparoscopy. To obtain tissue for examination, the doctor makes a small incision in the abdomen and inserts a special instrument into the abdominal cavity. If these procedures do not yield enough tissue, more extensive diagnostic surgery may be necessary.
Immunohistochemical studies play an important role for the pathologist in differentiating malignant mesothelioma from neoplastic mimics. There are numerous tests and panels available. No single test is perfect for distinguishing mesothelioma from carcinoma or even benign versus malignant. Currently, there is no FDA approved immunohistochemistry assay for the diagnosis of mesothelioma so different cancer centers use different panels.
Typical immunohistochemistry results
Positive Negative
EMA (epithelial membrane antigen) in a membranous distribution CEA (carcinoembryonic antigen)
WT1 (Wilms' tumour 1) B72.3
Calretinin[5] MOC-3 1
Mesothelin-1 CD15
Cytokeratin 5/6[5] Ber-EP4
HBME-1 (human mesothelial cell 1) TTF-1 (thyroid transcription factor-1)
There are three histological types of malignant mesothelioma: (1) Epithelioid; (2) Sarcomatoid; and (3) Biphasic (Mixed). Epithelioid comprises about 50-60% of malignant mesothelioma cases and generally holds a better prognosis than the Sarcomatoid or Biphasic subtypes.[27]

Staging

Staging of mesothelioma is based on the recommendation by the International Mesothelioma Interest Group.[28] TNM classification of the primary tumor, lymph node involvement, and distant metastasis is performed. Mesothelioma is staged Ia–IV (one-A to four) based on the TNM status.[28][29]

Screening

There is no universally agreed protocol for screening people who have been exposed to asbestos. Screening tests might diagnose mesothelioma earlier than conventional methods thus improving the survival prospects for patients. The serum osteopontin level might be useful in screening asbestos-exposed people for mesothelioma. The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.[30] Doctors have begun testing the Mesomark assay which measures levels of soluble mesothelin-related proteins (SMRPs) released by diseased mesothelioma cells.[31]

Pathophysiology


Diffuse pleural mesothelioma with extensive involvement of the pericardium.
The mesothelium consists of a single layer of flattened to cuboidal cells forming the epithelial lining of the serous cavities of the body including the peritoneal, pericardial and pleural cavities. Deposition of asbestos fibers in the parenchyma of the lung may result in the penetration of the visceral pleura from where the fiber can then be carried to the pleural surface, thus leading to the development of malignant mesothelial plaques. The processes leading to the development of peritoneal mesothelioma remain unresolved, although it has been proposed that asbestos fibers from the lung are transported to the abdomen and associated organs via the lymphatic system. Additionally, asbestos fibers may be deposited in the gut after ingestion of sputum contaminated with asbestos fibers.
Pleural contamination with asbestos or other mineral fibers has been shown to cause cancer. Long thin asbestos fibers (blue asbestos, amphibole fibers) are more potent carcinogens than "feathery fibers" (chrysotile or white asbestos fibers).[8] However, there is now evidence that smaller particles may be more dangerous than the larger fibers. They remain suspended in the air where they can be inhaled, and may penetrate more easily and deeper into the lungs. "We probably will find out a lot more about the health aspects of asbestos from [the World Trade Center attack], unfortunately," said Dr. Alan Fein, chief of pulmonary and critical-care medicine at North Shore-Long Island Jewish Health System. Dr. Fein has treated several patients for "World Trade Center syndrome" or respiratory ailments from brief exposures of only a day or two near the collapsed buildings.[32]
Mesothelioma development in rats has been demonstrated following intra-pleural inoculation of phosphorylated chrysotile fibers. It has been suggested that in humans, transport of fibers to the pleura is critical to the pathogenesis of mesothelioma. This is supported by the observed recruitment of significant numbers of macrophages and other cells of the immune system to localized lesions of accumulated asbestos fibers in the pleural and peritoneal cavities of rats. These lesions continued to attract and accumulate macrophages as the disease progressed, and cellular changes within the lesion culminated in a morphologically malignant tumor.
Experimental evidence suggests that asbestos acts as a complete carcinogen with the development of mesothelioma occurring in sequential stages of initiation and promotion. The molecular mechanisms underlying the malignant transformation of normal mesothelial cells by asbestos fibers remain unclear despite the demonstration of its oncogenic capabilities (see next-but-one paragraph). However, complete in vitro transformation of normal human mesothelial cells to malignant phenotype following exposure to asbestos fibers has not yet been achieved. In general, asbestos fibers are thought to act through direct physical interactions with the cells of the mesothelium in conjunction with indirect effects following interaction with inflammatory cells such as macrophages.
Analysis of the interactions between asbestos fibers and DNA has shown that phagocytosed fibers are able to make contact with chromosomes, often adhering to the chromatin fibers or becoming entangled within the chromosome. This contact between the asbestos fiber and the chromosomes or structural proteins of the spindle apparatus can induce complex abnormalities. The most common abnormality is monosomy of chromosome 22. Other frequent abnormalities include structural rearrangement of 1p, 3p, 9p and 6q chromosome arms.
Common gene abnormalities in mesothelioma cell lines include deletion of the tumor suppressor genes:
Asbestos has also been shown to mediate the entry of foreign DNA into target cells. Incorporation of this foreign DNA may lead to mutations and oncogenesis by several possible mechanisms:
Asbestos fibers have been shown to alter the function and secretory properties of macrophages, ultimately creating conditions which favour the development of mesothelioma. Following asbestos phagocytosis, macrophages generate increased amounts of hydroxyl radicals, which are normal by-products of cellular anaerobic metabolism. However, these free radicals are also known clastogenic and membrane-active agents thought to promote asbestos carcinogenicity. These oxidants can participate in the oncogenic process by directly and indirectly interacting with DNA, modifying membrane-associated cellular events, including oncogene activation and perturbation of cellular antioxidant defences.
Asbestos also may possess immunosuppressive properties. For example, chrysotile fibres have been shown to depress the in vitro proliferation of phytohemagglutinin-stimulated peripheral blood lymphocytes, suppress natural killer cell lysis and significantly reduce lymphokine-activated killer cell viability and recovery. Furthermore, genetic alterations in asbestos-activated macrophages may result in the release of potent mesothelial cell mitogens such as platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β) which in turn, may induce the chronic stimulation and proliferation of mesothelial cells after injury by asbestos fibres.

Treatment

The prognosis for malignant mesothelioma remains disappointing, although there have been some modest improvements in prognosis from newer chemotherapies and multimodality treatments.[33] Treatment of malignant mesothelioma at earlier stages has a better prognosis, but cures are exceedingly rare. Clinical behavior of the malignancy is affected by several factors including the continuous mesothelial surface of the pleural cavity which favors local metastasis via exfoliated cells, invasion to underlying tissue and other organs within the pleural cavity, and the extremely long latency period between asbestos exposure and development of the disease. The histological subtype and the patient's age and health status also help predict prognosis. The epithelioid histology responds better to treatment and has a survival advantage over sarcomatoid histology.[34]

Surgery

Surgery, by itself, has proved disappointing. In one large series, the median survival with surgery (including extrapleural pneumonectomy) was only 11.7 months.[33] However, research indicates varied success when used in combination with radiation and chemotherapy (Duke, 2008), or with one of the latter. A pleurectomy/decortication is the most common surgery, in which the lining of the chest is removed. Less common is an extrapleural pneumonectomy (EPP), in which the lung, lining of the inside of the chest, the hemi-diaphragm and the pericardium are removed.

Radiation

For patients with localized disease, and who can tolerate a radical surgery, radiation can be given post-operatively as a consolidative treatment. The entire hemi-thorax is treated with radiation therapy, often given simultaneously with chemotherapy. Delivering radiation and chemotherapy after a radical surgery has led to extended life expectancy in selected patient populations. It also can induce severe side-effects, including fatal pneumonitis.[35] As part of a curative approach to mesothelioma, radiotherapy is commonly applied to the sites of chest drain insertion, in order to prevent growth of the tumor along the track in the chest wall.
Although mesothelioma is generally resistant to curative treatment with radiotherapy alone, palliative treatment regimens are sometimes used to relieve symptoms arising from tumor growth, such as obstruction of a major blood vessel. Radiation therapy when given alone with curative intent has never been shown to improve survival from mesothelioma. The necessary radiation dose to treat mesothelioma that has not been surgically removed would be very toxic.

Chemotherapy

Chemotherapy is the only treatment for mesothelioma that has been proven to improve survival in randomised and controlled trials. The landmark study published in 2003 by Vogelzang and colleagues compared cisplatin chemotherapy alone with a combination of cisplatin and pemetrexed (brand name Alimta) chemotherapy in patients who had not received chemotherapy for malignant pleural mesothelioma[36] previously and were not candidates for more aggressive "curative" surgery.[37] This trial was the first to report a survival advantage from chemotherapy in malignant pleural mesothelioma, showing a statistically significant improvement in median survival from 10 months in the patients treated with cisplatin alone to 13.3 months in the group of patients treated with cisplatin in the combination with pemetrexed and who also received supplementation with folate and vitamin B12. Vitamin supplementation was given to most patients in the trial and pemetrexed related side effects were significantly less in patients receiving pemetrexed when they also received daily oral folate 500mcg and intramuscular vitamin B12 1000mcg every 9 weeks compared with patients receiving pemetrexed without vitamin supplementation. The objective response rate increased from 20% in the cisplatin group to 46% in the combination pemetrexed group. Some side effects such as nausea and vomiting, stomatitis, and diarrhoea were more common in the combination pemetrexed group but only affected a minority of patients and overall the combination of pemetrexed and cisplatin was well tolerated when patients received vitamin supplementation; both quality of life and lung function tests improved in the combination pemetrexed group. In February 2004, the United States Food and Drug Administration approved pemetrexed for treatment of malignant pleural mesothelioma. However, there are still unanswered questions about the optimal use of chemotherapy, including when to start treatment, and the optimal number of cycles to give.
Cisplatin in combination with raltitrexed has shown an improvement in survival similar to that reported for pemetrexed in combination with cisplatin, but raltitrexed is no longer commercially available for this indication. For patients unable to tolerate pemetrexed, cisplatin in combination with gemcitabine or vinorelbine is an alternative, or vinorelbine on its own, although a survival benefit has not been shown for these drugs. For patients in whom cisplatin cannot be used, carboplatin can be substituted but non-randomised data have shown lower response rates and high rates of haematological toxicity for carboplatin-based combinations, albeit with similar survival figures to patients receiving cisplatin.[38]
In January 2009, the United States FDA approved using conventional therapies such as surgery in combination with radiation and or chemotherapy on stage I or II Mesothelioma after research conducted by a nationwide study by Duke University concluded an almost 50 point increase in remission rates.

Immunotherapy

Treatment regimens involving immunotherapy have yielded variable results. For example, intrapleural inoculation of Bacillus Calmette-Guérin (BCG) in an attempt to boost the immune response, was found to be of no benefit to the patient (while it may benefit patients with bladder cancer). Mesothelioma cells proved susceptible to in vitro lysis by LAK cells following activation by interleukin-2 (IL-2), but patients undergoing this particular therapy experienced major side effects. Indeed, this trial was suspended in view of the unacceptably high levels of IL-2 toxicity and the severity of side effects such as fever and cachexia. Nonetheless, other trials involving interferon alpha have proved more encouraging with 20% of patients experiencing a greater than 50% reduction in tumor mass combined with minimal side effects.

Heated intraoperative intraperitoneal chemotherapy

This technique is used in conjunction with surgery,[39] including in patients with malignant pleural mesothelioma.[40] The surgeon removes as much of the tumor as possible followed by the direct administration of a chemotherapy agent, heated to between 40 and 48°C, in the abdomen. The fluid is perfused for 60 to 120 minutes and then drained. High concentrations of selected drugs are then administered into the abdominal and pelvic surfaces. Heating the chemotherapy treatment increases the penetration of the drugs into tissues. Also, heating itself damages the malignant cells more than the normal cells.

Multimodality therapy

All of the standard approaches to treating solid tumors—radiation, chemotherapy, and surgery—have been investigated in patients with malignant pleural mesothelioma. Although surgery, by itself, is not very effective, surgery combined with adjuvant chemotherapy and radiation (trimodality therapy) has produced significant survival extension (3–14 years) among patients with favorable prognostic factors.[41] However, other large series of examining multimodality treatment have only demonstrated modest improvement in survival (median survival 14.5 months and only 29.6% surviving 2 years).[33] Reducing the bulk of the tumor with cytoreductive surgery is key to extending survival. Two surgeries have been developed: extrapleural pneumonectomy and pleurectomy/decortication. The indications for performing these operations are unique. The choice of operation namely depends on the size of the patient's tumor. This is an important consideration because tumor volume has been identified as a prognostic factor in mesothelioma.[42] Pleurectomy/decortication spares the underlying lung and is performed in patients with early stage disease when the intention is to remove all gross visible tumor (macroscopic complete resection), not simply palliation.[43] Extrapleural pneumonectomy is a more extensive operation that involves resection of the parietal and visceral pleurae, underlying lung, ipsilateral diaphragm, and ipsilateral pericardium. This operation is indicated for a subset of patients with more advanced tumors, who can tolerate a pneumonectomy.[44]

Alternative medicine

The medicinal plant Ashwagandha (Withania somnifera) has long been used in Indian Ayurvedic medicine. An extract of this plant, Withaferin A (WA), has been tested in vitro and in vivo as a treatment for malignant pleural mesothelioma (MPM). The authors of these tests have concluded that their data "convincingly demonstrate that WA targets multiple pathways to suppress MPM growth in vitro and in vivo, and underscore its potential as a future anti-MPM therapy".[45] Ashwagandha extracts are commercially manufactured and widely available.

Epidemiology

Although reported incidence rates have increased in the past 20 years, mesothelioma is still a relatively rare cancer. The incidence rate varies from one country to another, from a low rate of less than 1 per 1,000,000 in Tunisia and Morocco, to the highest rate in Britain, Australia and Belgium: 30 per 1,000,000 per year.[46] For comparison, populations with high levels of smoking can have a lung cancer incidence of over 1,000 per 1,000,000. Incidence of malignant mesothelioma currently ranges from about 7 to 40 per 1,000,000 in industrialized Western nations, depending on the amount of asbestos exposure of the populations during the past several decades.[47] It has been estimated that incidence may have peaked at 15 per 1,000,000 in the United States in 2004. Incidence is expected to continue increasing in other parts of the world. Mesothelioma occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age. Approximately one fifth to one third of all mesotheliomas are peritoneal.
Between 1940 and 1979, approximately 27.5 million people were occupationally exposed to asbestos in the United States.[48] Between 1973 and 1984, the incidence of pleural mesothelioma among Caucasian males increased 300%. From 1980 to the late 1990s, the death rate from mesothelioma in the USA increased from 2,000 per year to 3,000, with men four times more likely to acquire it than women.
The incidence of peritoneal mesothelioma is 0.5–3.0 per million per year in men, and 0.2–2.0 per million per year in women.[49]

Society and culture

Notable cases

Mesothelioma, though rare, has had a number of notable patients:
  • Bernie Banton, an Australian workers' rights activist, fought a long battle for compensation from James Hardie after he contracted mesothelioma after working for that company. He claimed James Hardie knew of the dangers of asbestos before he began work with the substance making insulation for power stations. Mesothelioma eventually took his life along with his brothers and hundreds of James Hardie workers. James Hardie made an undisclosed settlement with Banton only when his mesothelioma had reached its final stages and he was expected to have no more than 48 hours to live. Australian Prime Minister Kevin Rudd mentioned Banton's extended struggle in his acceptance speech after winning the 2007 Australian federal election.
  • Bob Bellear, Australian anti-racism activist, died in 2005.
  • Frank Bender, American forensic sculptor and co-founder of the Vidocq Society, died in 2011.
  • Michael G. Coney, British science fiction writer, responsible for nearly 100 works, died in 2005.
  • Paul Gleason, American film and television actor perhaps best known for his portrayal of Principal Richard Vernon in the 1985 film The Breakfast Club, died in 2006.
  • Christie Hennessy, the influential Irish singer-songwriter, died of mesothelioma in 2007, and had stridently refused to accept the prognosis in the weeks before his death.[50] Hennessy's mesothelioma has been attributed to his younger years spent working on building sites in London.[51]
  • Richard J. Herrnstein, psychologist and co-author of The Bell Curve, died in 1994.
  • Harold Hopkins, Australian actor who appeared in films such as The Club, Don's Party, Gallipoli, and the TV mini series Sara Dane died from mesothelioma on December 11, 2011 in a Sydney hospital.[52]
  • Hamilton Jordan, Chief of Staff for U.S. President Jimmy Carter and lifelong cancer activist, died in 2008.
  • Lincoln Hall, pioneering Australian mountaineer and a founding director of the Australian Himalayan Foundation. He had previously survived against slim odds stranded near the summit of Mount Everest with altitude sickness in 2006. He passed from mesothelioma in 2012.
  • Peter Leonard, Australian journalist and news presenter from Canberra, died September 23, 2008.
  • Malcolm McLaren, former manager of New York Dolls and Sex Pistols, died on 8 April 2010.
  • John William MacDougall, Scottish Labour MP, died of mesothelioma on August 13, 2008, after fighting the disease for two years.[53]
  • Steve McQueen, American actor, was diagnosed with peritoneal mesothelioma on December 22, 1979. He was not offered surgery or chemotherapy because doctors felt the cancer was too advanced. McQueen subsequently sought alternative treatments at clinics in Mexico. He died of a heart attack on November 7, 1980, in Juárez, Mexico, following cancer surgery. He may have been exposed to asbestos while serving with the U.S. Marines as a young adult—asbestos was then commonly used to insulate ships' piping—or from its use as an insulating material in automobile racing suits (McQueen was an avid racing driver and fan).[54]
  • Bob Miner, one of the founders of Software Development Labs, the forerunner of Oracle Corporation, died of mesothelioma in 1994.
  • Terrence McCann, Olympic gold medalist and longtime Executive Director of Toastmasters, died of mesothelioma on June 7, 2006, at his home in Dana Point, California.
  • Mickie Most, an English record producer, died of mesothelioma in 2003.
  • Merlin Olsen, Pro Football Hall of Famer and television actor, died on March 10, 2010, from mesothelioma that had been diagnosed in 2009.
  • Paul Rudolph, American architect, died in 1997.
  • Sean Sasser, American AIDS activist and cast member of MTV's 1994 reality series, The Real World: San Francisco, died in August 2013.[55]
  • Billy Vaughn, American bandleader, died in 1991.
  • Bruce Vento, U.S. Congressman, died of mesothelioma in 2000. The Bruce Vento Hopebuilder award is given yearly by his wife at the MARF Symposium to persons or organizations who have done the most to support mesothelioma research and advocacy.
  • Warren Zevon, rock and roll musician and songwriter. After a long period of untreated illness and pain, Zevon was diagnosed with inoperable mesothelioma in the fall of 2002. Refusing treatments that he believed might incapacitate him, Zevon focused his energies on recording his final album The Wind, including the song "Keep Me in Your Heart," which speaks of his failing breath. Zevon died at his home in Los Angeles, California, on September 7, 2003.
  • Admiral Elmo Zumwalt, former head of the U.S. Navy [56]
  • Ed Lauter, American actor and stand-up comedian. Died October 16, 2013.

People who have lived for some time with mesothelioma

Although life expectancy with this disease is typically limited, there are notable survivors. In July 1982, Stephen Jay Gould, a well-regarded paleontologist, was diagnosed with peritoneal mesothelioma. After his diagnosis, Gould wrote "The Median Isn't the Message",[57] in which he argued that statistics such as median survival are useful abstractions, not destiny. Gould lived for another 20 years, eventually succumbing to a cancer not linked to his mesothelioma.
Paul Kraus, diagnosed in 1997, is considered the longest living mesothelioma survivor in the world.

Legal issues

Some people who were exposed to asbestos have collected damages for asbestos-related disease, including mesothelioma. Compensation via asbestos funds or class action lawsuits is an important issue in law practices regarding mesothelioma (see asbestos and the law).
The first lawsuits against asbestos manufacturers were in 1929. Since then, many lawsuits have been filed against asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known (some reports seem to place this as early as 1898). The liability resulting from the sheer number of lawsuits and people affected has reached billions of dollars.[58] The amounts and method of allocating compensation have been the source of many court cases, reaching up to the United States Supreme Court, and government attempts at resolution of existing and future cases. However, to date, the US Congress has not stepped in and there are no federal laws governing asbestos compensation.[59]
History
The first lawsuit against asbestos manufacturers was brought in 1929. The parties settled that lawsuit, and as part of the agreement, the attorneys agreed not to pursue further cases. In 1960, an article published by Wagner et al. was seminal in establishing mesothelioma as a disease arising from exposure to asbestos.[60] The article referred to over 30 case studies of people who had suffered from mesothelioma in South Africa. Some exposures were transient and some were mine workers. Prior to the use of advanced microscopy techniques, malignant mesothelioma was often diagnosed as a variant form of lung cancer.[61] In 1962 McNulty reported the first diagnosed case of malignant mesothelioma in an Australian asbestos worker.[62] The worker had worked in the mill at the asbestos mine in Wittenoom from 1948 to 1950.
In the town of Wittenoom, asbestos-containing mine waste was used to cover schoolyards and playgrounds. In 1965 an article in the British Journal of Industrial Medicine established that people who lived in the neighbourhoods of asbestos factories and mines, but did not work in them, had contracted mesothelioma.
Despite proof that the dust associated with asbestos mining and milling causes asbestos-related disease, mining began at Wittenoom in 1943 and continued until 1966. In 1974 the first public warnings of the dangers of blue asbestos were published in a cover story called "Is this Killer in Your Home?" in Australia's Bulletin magazine. In 1978 the Western Australian Government decided to phase out the town of Wittenoom, following the publication of a Health Dept. booklet, "The Health Hazard at Wittenoom", containing the results of air sampling and an appraisal of worldwide medical information.
By 1979 the first writs for negligence related to Wittenoom were issued against CSR and its subsidiary ABA, and the Asbestos Diseases Society was formed to represent the Wittenoom victims.
In Leeds, England the Armley asbestos disaster involved several court cases against Turner & Newall where local residents who contracted mesothelioma claimed compensation because of the asbestos pollution from the company's factory. One notable case was that of June Hancock, who contracted the disease in 1993 and died in 1997

Senin, 06 Mei 2013

New Internet Download Manager V6.15

New! Internet Download Manager v6.15. Added Windows 8 compatibility. Fixed compatibility problems with different browsers including Internet Explorer 10, all Mozilla Firefox versions up to Mozilla Firefox Aurora, Google Chrome. Improved FLV grabber to save videos from web players on YouTube, WOW! Google Video, MySpace TV, and other popular sites

Internet Download Manager (IDM) is a tool to increase download speeds by up to 5 times, resume and schedule downloads. Comprehensive error recovery and resume capability will restart broken or interrupted downloads due to lost connections, network problems, computer shutdowns, or unexpected power outages. Simple graphic user interface makes IDM user friendly and easy to use.Internet Download Manager has a smart download logic accelerator that features intelligent dynamic file segmentation and safe multipart downloading technology to accelerate your downloads. Unlike other download managers and accelerators Internet Download Manager segments downloaded files dynamically during download process and reuses available connections without additional connect and login stages to achieve best acceleration performance.
Internet Download Manager supports proxy servers, ftp and http protocols, firewalls, redirects, cookies, authorization, MP3 audio and MPEG video content processing. IDM integrates seamlessly into Microsoft Internet Explorer, Netscape, MSN Explorer, AOL, Opera, Mozilla, Mozilla Firefox, Mozilla Firebird, Avant Browser, MyIE2, and all other popular browsers to automatically handle your downloads. You can also drag and drop files, or use Internet Download Manager from command line. Internet Download Manager can dial your modem at the set time, download the files you want, then hang up or even shut down your computer when it's done.

Other features include multilingual support, zip preview, download categories, scheduler pro, sounds on different events, HTTPS support, queue processor, html help and tutorial, enhanced virus protection on download completion, progressive downloading with quotas (useful for connections that use some kind of fair access policy or FAP like Direcway, Direct PC, Hughes, etc.), built-in download accelerator, and many others.
Version 6.15 adds Windows 8 compatibility, adds IDM download panel for web-players that can be used to download flash videos from sites like YouTube, MySpaceTV, and Google Videos. It also features complete Windows 7 and Vista support, YouTube grabber, redeveloped scheduler, and MMS protocol support. The new version also adds improved integration for IE 10 and IE based browsers, redesigned and enhanced download engine, the unique advanced integration into all latest browsers, improved toolbar, and a wealth of other improvements and new features.

Jumat, 26 April 2013

The Eugenicists Think You’re Stupid: “First Vaccine To Help Control Autism”

130424112309by Chris and Sheree Geo
Truth Frequency Radio
Yes, you heard that right: a vaccine for autism. According to Science Daily:
A first-ever vaccine created by University of Guelph researchers for gut bacteria common in autistic children may also help control some autism symptoms.
Read about the sheer madness here
What they’re doing with this is essentially vindicating Dr. Wakefield’s autism research connecting vaccination to harmful gut bacteria that causes autism, while at the same time promoting the culprit as the “cure”.
They developed a carbohydrate-based vaccine against the gut bug Clostridium bolteae.
C. bolteae is known to play a role in gastrointestinal disorders, and it often shows up in higher numbers in the GI tracts of autistic children than in those of healthy kids.
More than 90 per cent of children with autism spectrum disorders suffer from chronic, severe gastrointestinal symptoms. Of those, about 75 per cent suffer from diarrhea, according to current literature.
“Little is known about the factors that predispose autistic children to C. bolteae,” said Monteiro. Although most infections are handled by some antibiotics, he said, a vaccine would improve current treatment.
It’s interesting to see how eugenicists will use good science from doctors they’ve crucified to try to promote the very thing the crucified doctor warned against. Dr. Wakefield has caused so much damage to the vaccine industry with his groundbreaking research, even Bill Gates denounces him publicly on national television (remember: his research is what the above article is really all about – he discovered C. Bolteae, and said it was caused by vaccines)

Plant Based Drugs and Medicines

By Leslie Taylor, ND
October 13, 2000


For more on this subject, also see Chapter 2 of The Healing Power of Rainforest Herbs.


Today there are at least 120 distinct chemical substances derived from plants that are considered as important drugs currently in use in one or more countries in the world. These chemical substances are shown in the table below. Several of the drugs sold today are simple synthetic modifications or copies of the naturally obtained substances. The original plant substance/chemical name is shown under the "Drug" column rather than the finished patented drug name. For example, many years ago a plant chemical was discovered in a tropical plant, Cephaelis ipecacuanha, and the chemical was named emetine. A drug was developed from this plant chemical called Ipecac which was used for many years to induce vomiting mostly if someone accidently swallowed a poisonous or harmful substance. Ipecac can still be found in pharmacies in many third world countries but has been mostly replaced by other drugs in the United States. Another example of this is the plant chemical named taxol shown in the drug column below. The name taxol is the name of the plant chemical orginally discovered in the plant. A pharmaceutical company copied this chemical and patented a drug named Paclitaxel™ which is used in various types of tumors today in the U.S. and many other countries.
The 120 substances shown below are sold as drugs worldwide but not in all countries. Some European countries regulate herbal sustances and products differently than in the United States. Many European countries, including Germany, regulate herbal products as drugs and pharmaceutical companies prepare plant based drugs simply by extracting out the active chemicals from the plants. A good example is the plant substance/drug shown below, cynarin. Cynarin is a plant chemical found in the common artichoke (Cynara scolymus). In Germany, a cynarin drug is sold for liver problems and hypertension which is simply this one chemical extracted from the artichoke plant or a plant extract which has been standardized to contain a specific milligram amount of this one chemical. These products are manufactured by pharmaceutical companies, sold in pharmacies in Germany and a doctor's prescription is required to purchase them. In the United States artichoke extracts are available as natural products and sold in health food stores. Some products are even standardized to contain a specific amount of the cynarin chemical. You can purchase these natural and standardized extracts over the counter without a prescription and you could not go to a pharmacy in the U.S. and obtain a cynarin drug with a prescription. Another similar example is the plant chemical, silymarin, shown in the drug column below. Silymarin is a chemical found in the milk thistle plant and natural milk thistle extracts standarized to contain specific amounts of silymarin are found in just about every health food store in the United States. However in Germany, silymarin drugs and milk thistle standardized extracts are sold only in pharmacies and require a doctor's prescription for liver problems.
Some of the drug/chemicals shown below are still sold as plant based drugs requiring the processing of the actual plant material. Others have been chemically copied or synthesized by laboratories and no plant materials are used in the manufacture of the drug. A good example of this is the plant chemical quinine, which was discovered in a rainforest tree (Cinchona ledgeriana) over 100 years ago. For many years the quinine chemical was extracted from the bark of this tree and processed into pills to treat malaria. Then a scientist was able to synthesize or copy this plant alkaloid into a chemical drug without using the original tree bark for manufacturing the drug. Today, all quinine drugs sold are manufactured chemically without the use of any tree bark. However, another chemical in the tree called quinidine which was found to be useful for various heart conditions couldn't be completely copied in the laboratory and the tree bark is still harvested and used to extract this plant chemical from it. Quinidine extracted from the bark is still used today to produce quinidine-based drugs. In the U.S. there are four patented brand-name heart drugs sold in pharmacies containing bark-extracted quinidine: Cardioquin™, Quinaglute Dura-tabs™, Quinidex Extentabs™ and Quin-Release™.
The following table below will help you begin your research on drugs made from plants. We don't have the time or resources to provide a full comprehensive list of all patented drug names and herbal drugs sold in other countries. The chemical/drug names and plant names will give you enough to start on to continue your research on important plant based drugs and medicines.


Drug/Chemical Action/Clinical Use Plant Source
Acetyldigoxin Cardiotonic Digitalis lanata
Adoniside Cardiotonic Adonis vernalis
Aescin Anti-inflammatory Aesculus hippocastanum
Aesculetin Anti-dysentery Frazinus rhychophylla
Agrimophol Anthelmintic Agrimonia supatoria
Ajmalicine Circulatory Disorders Rauvolfia sepentina
Allantoin Vulnerary Several plants
Allyl isothiocyanate Rubefacient Brassica nigra
Anabesine Skeletal muscle relaxant Anabasis sphylla
Andrographolide Baccillary dysentery Andrographis paniculata
Anisodamine Anticholinergic Anisodus tanguticus
Anisodine Anticholinergic Anisodus tanguticus
Arecoline Anthelmintic Areca catechu
Asiaticoside Vulnerary Centella asiatica
Atropine Anticholinergic Atropa belladonna
Benzyl benzoate Scabicide Several plants
Berberine Bacillary dysentery Berberis vulgaris
Bergenin Antitussive Ardisia japonica
Betulinic acid Anticancerous Betula alba
Borneol Antipyretic, analgesic, antiinflammatory Several plants
Bromelain Anti-inflammatory, proteolytic Ananas comosus
Caffeine CNS stimulant Camellia sinensis
Camphor Rubefacient Cinnamomum camphora
Camptothecin Anticancerous Camptotheca acuminata
(+)-Catechin Haemostatic Potentilla fragarioides
Chymopapain Proteolytic, mucolytic Carica papaya
Cissampeline Skeletal muscle relaxant Cissampelos pareira
Cocaine Local anaesthetic Erythroxylum coca
Codeine Analgesic, antitussive Papaver somniferum
Colchiceine amide Antitumor agent Colchicum autumnale
Colchicine Antitumor agent, anti-gout Colchicum autumnale
Convallatoxin Cardiotonic Convallaria majalis
Curcumin Choleretic Curcuma longa
Cynarin Choleretic Cynara scolymus
Danthron Laxative Cassia species
Demecolcine Antitumor agent Colchicum autumnale
Deserpidine Antihypertensive, tranquillizer Rauvolfia canescens
Deslanoside Cardiotonic Digitalis lanata
L-Dopa Anti-parkinsonism Mucuna sp
Digitalin Cardiotonic Digitalis purpurea
Digitoxin Cardiotonic Digitalis purpurea
Digoxin Cardiotonic Digitalis purpurea
Emetine Amoebicide, emetic Cephaelis ipecacuanha
Ephedrine Sympathomimetic, antihistamine Ephedra sinica
Etoposide Antitumor agent Podophyllum peltatum
Galanthamine Cholinesterase inhibitor Lycoris squamigera
Gitalin Cardiotonic Digitalis purpurea
Glaucarubin Amoebicide Simarouba glauca
Glaucine Antitussive Glaucium flavum
Glasiovine Antidepressant Octea glaziovii
Glycyrrhizin Sweetener, Addison's disease Glycyrrhiza glabra
Gossypol Male contraceptive Gossypium species
Hemsleyadin Bacillary dysentery Hemsleya amabilis
Hesperidin Capillary fragility Citrus species
Hydrastine Hemostatic, astringent Hydrastis canadensis
Hyoscyamine Anticholinergic Hyoscyamus niger
Irinotecan Anticancer, antitumor agent Camptotheca acuminata
Kaibic acud Ascaricide Digenea simplex
Kawain Tranquillizer Piper methysticum
Kheltin Bronchodilator Ammi visaga
Lanatosides A, B, C Cardiotonic Digitalis lanata
Lapachol Anticancer, antitumor Tabebuia sp.
a-Lobeline Smoking deterrant, respiratory stimulant Lobelia inflata
Menthol Rubefacient Mentha species
Methyl salicylate Rubefacient Gaultheria procumbens
Monocrotaline Antitumor agent (topical) Crotalaria sessiliflora
Morphine Analgesic Papaver somniferum
Neoandrographolide Dysentery Andrographis paniculata
Nicotine Insecticide Nicotiana tabacum
Nordihydroguaiaretic acid Antioxidant Larrea divaricata
Noscapine Antitussive Papaver somniferum
Ouabain Cardiotonic Strophanthus gratus
Pachycarpine Oxytocic Sophora pschycarpa
Palmatine Antipyretic, detoxicant Coptis japonica
Papain Proteolytic, mucolytic Carica papaya
Papavarine Smooth muscle relaxant Papaver somniferum
Phyllodulcin Sweetner Hydrangea macrophylla
Physostigmine Cholinesterase Inhibitor Physostigma venenosum
Picrotoxin Analeptic Anamirta cocculus
Pilocarpine Parasympathomimetic Pilocarpus jaborandi
Pinitol Expectorant Several plants
Podophyllotoxin Antitumor anticancer agent Podophyllum peltatum
Protoveratrines A, B Antihypertensives Veratrum album
Pseudoephredrine* Sympathomimetic Ephedra sinica
Pseudoephedrine, nor- Sympathomimetic Ephedra sinica
Quinidine Antiarrhythmic Cinchona ledgeriana
Quinine Antimalarial, antipyretic Cinchona ledgeriana
Qulsqualic acid Anthelmintic Quisqualis indica
Rescinnamine Antihypertensive, tranquillizer Rauvolfia serpentina
Reserpine Antihypertensive, tranquillizer Rauvolfia serpentina
Rhomitoxin Antihypertensive, tranquillizer Rhododendron molle
Rorifone Antitussive Rorippa indica
Rotenone Piscicide, Insecticide Lonchocarpus nicou
Rotundine Analagesic, sedative, traquillizer Stephania sinica
Rutin Capillary fragility Citrus species
Salicin Analgesic Salix alba
Sanguinarine Dental plaque inhibitor Sanguinaria canadensis
Santonin Ascaricide Artemisia maritma
Scillarin A Cardiotonic Urginea maritima
Scopolamine Sedative Datura species
Sennosides A, B Laxative Cassia species
Silymarin Antihepatotoxic Silybum marianum
Sparteine Oxytocic Cytisus scoparius
Stevioside Sweetner Stevia rebaudiana
Strychnine CNS stimulant Strychnos nux-vomica
Taxol Antitumor agent Taxus brevifolia
Teniposide Antitumor agent Podophyllum peltatum
a-Tetrahydrocannabinol(THC) Antiemetic, decrease occular tension Cannabis sativa
Tetrahydropalmatine Analgesic, sedative, traquillizer Corydalis ambigua
Tetrandrine Antihypertensive Stephania tetrandra
Theobromine Diuretic, vasodilator Theobroma cacao
Theophylline Diuretic, brochodilator Theobroma cacao and others
Thymol Antifungal (topical) Thymus vulgaris
Topotecan Antitumor, anticancer agent Camptotheca acuminata
Trichosanthin Abortifacient Trichosanthes kirilowii
Tubocurarine Skeletal muscle relaxant Chondodendron tomentosum
Valapotriates Sedative Valeriana officinalis
Vasicine Cerebral stimulant Vinca minor
Vinblastine Antitumor, Antileukemic agent Catharanthus roseus
Vincristine Antitumor, Antileukemic agent Catharanthus roseus
Yohimbine Aphrodisiac Pausinystalia yohimbe
Yuanhuacine Abortifacient Daphne genkwa
Yuanhuadine Abortifacient Daphne genkwa


CANCER AND AIDS RESEARCH

Searching for the cures

The National Cancer Institute (NCI) has several ongoing collabrative programs which screen plants for the possiblility of new drugs and active plant chemicals for cancer and AIDS/HIV.
Because well over 50 percent of the estimated 250,000 plant species found on earth come from tropical forests, NCI concentrates on these regions. Plants have been collected from the African countries of Cameroon, the Central African Republic, Gabon, Ghana, Madagascar, and Tanzania. Collections are now concentrated in Madagascar (one of the most rapidly dissappearing rainforest regions in the world), and collaborative programs have been established in South Africa and Zimbabwe.
In Central and South America, samples have been collected from Belize, Bolivia, Colombia, the Dominican Republic, Ecuador, Guatemala, Guyana, Honduras, Martinique, Paraguay, Peru, and Puerto Rico. The NCI has established collaborative programs in Brazil, Costa Rica, Mexico, and Panama. Southeast Asian collections have been performed in Bangladesh, Indonesia, Laos, Malaysia, Nepal, Pakistan, Papua New Guinea, the Philippines, Taiwan, Thailand, and Vietnam. Collaborative programs have been established in Bangladesh, China, Korea, and Pakistan. In each country, NCI contractors work in close collaboration with local botanical institutions.
These collabrative programs include the following:
  • The South American Organization for Anticancer Drug Development (SOAD) in Porto Alegre, Fundacao Oswaldo Cruz-FIOCRUZ in Rio de Janeiro, and the University Paulista in Sao Paulo investigate plants from Brazil.
  • The Institute of Biological Diversity (INBio) in Costa Rica studies insects and plants.
  • The Institute of Chemistry, National University of Mexico, studies medicinal plants.
  • The Kunming Institute of Botany in China studies Chinese medicinal plants.
  • The Korean Research Institute of Chemical Technology examines Korean medicinal plants.
  • The H.E.J. Institute of Chemistry, University of Karachi, studies Pakistani plants.
  • The University of Dhaka in Bangladesh studies plants and microbes.
  • University of Panama studies Panamanian medicinal plants.
  • Brigham Young University (Dr. Paul Cox) studies Polynesian medicinal plants.
  • Tel Aviv University (Dr. Yoel Kashman) studies Red Sea marine invertebrates.
  • The New Zealand National Institute of Water and Atmospheric Research studies marine organisms.
  • The Cancer Research Center at the Russian Academy of Medical Sciences in Moscow studies Russian medicinal plants.
  • The Zimbabwe National Traditional Healers Association and the University of Zimbabwe study Zimbabwean medicinal plants.
  • The South African Council for Scientific and Industrial Research studies South African plants.


Thus far seven plant-derived anticancer drugs have received Food and Drug Administration (FDA) approval for commercial production:
  • Taxol / Paclitaxel
    A chemical discovered in the Pacific Yew tree (Taxus brevifolia) is now the first drug of choice in several tumorous cancers including Breast Cancer.
  • Vinblastine
    A chemical discovered in the Madagascar Periwinkle in the 1950s. Vinblastine is the first drug of choice in many forms of leukemia and since the 1950's it has increased the survival rate of childhood leukemias by 80%
  • Vincristine
    Another antileukemic drug discovered in the Madagascar periwinkle.
  • Topotecan
    Has been approved by the FDA for the treatment of ovarian and small cell lung cancers. It is currently in clinical trials, either alone or in combination with other anticancer drugs, for several types of cancer. Topotecan is a analog (a synthesized chemical) of a plant alkaloid discovered in the Chinese tree species, Camptotheca acuminata
  • Irinotecan
    Another chemical analog which has been developed from yet another plant alkaloid discovered in the same tree Camptotheca acuminata. It has been approved by the FDA for the treatment of metastatic colorectal cancer. It is currently in clinical trials for a variety of other cancers.
  • Etoposide
    A semisynthetic derivative of a plant chemical epipodophyllotoxin discovered in the Mayapple plant family (Podophyllum peltatum)
  • Teniposide
    Another semisynthetic derivative of a plant chemical discovered in the Mayapple plant family (Podophyllum peltatum).
Since 1986, over 40,000 plant samples have been screened, but thus far only five chemicals showing significant activity against AIDS have been isolated. Three are currently in preclinical development. Before being considered for clinical trials in humans, these agents must show tolerable levels of toxicity in several animal models. For AIDS, three agents are presently in preclinical or early clinical development. The following are plants and chemicals which are still under research for cancer and AIDS/HIV:
  • (+)-Calanolide A and (-)-Calanolide B (costatolide) are isolated from Calophyllum lanigerum and Calophyllum teysmanii, respectively, trees found in Sarawak, Malaysia. Both these agents are licensed to Medichem, Inc., Chicago, which is developing them in collaboration with the Sarawak State Government through a joint company, Sarawak Medichem Pharmaceuticals, Inc. (+)-Calanolide A is currently in early clinical trials in the United States.
  • Conocurovone, isolated from the shrub species, Conospermum incurvum (saltbush), found in Western Australia, has been licensed for development to AMRAD, a company based in Victoria, Australia.
  • Michellamine B, from the leaves of Ancistrocladus korupensis, a vine found in the Korup rainforest region of southwest Cameroon, has undergone extensive preclinical study, but is considered too toxic for advancement to clinical trials.
  • Prostratin, isolated from the wood of Homolanthus nutans, a tree found in Western Samoa, has been placed on low priority, largely due to its association with a class of compounds shown to be tumor promoters.
  • A tree native to China--Camptotheca acuminata--is the source of four promising anticancer drugs, two of which have been approved by the FDA and are described above. The other two chemicals still under research include:
    • 9AC (9-aminocamptothecin): Currently in clinical trials for several types of cancer, including ovarian and stomach cancers and T-cell lymphoma.
    • Camptothecin: While no clinical trials are being performed in the United States, trials are ongoing in China.
  • Homoharringtonine from the Chinese tree, Cephalotaxus harringtonia are in early clinical trials.
  • Perillyl alcohol, and flavopiridol, a totally synthetic compound based on a flavone isolated from Dysoxylum binectiferum are in early clinical trials.


    The above text has been authored by Leslie Taylor, Milam County, Texas 77857 and copyrighted © 2000. All rights reserved. Please refer to the Copyright Statement on permitted uses of this document.



    *The statements contained herein have not been evaluated
    by the Food and Drug Administration. This information is provided for educational and entertainment use only. Nothing herein is intended to treat, cure, mitigate or prevent any disease.
    Please refer to our Conditions of Use for this web site. 
     
    http://www.rain-tree.com/plantdrugs.htm#.UXswa0qIzIU
 

tradicional medicine Copyright © 2012 Fast Loading -- Powered by Blogger